Cloquintocet-mexyl; Pesticide Tolerances, 16017-16020 [2010-6890]
Download as PDF
Federal Register / Vol. 75, No. 61 / Wednesday, March 31, 2010 / Rules and Regulations
10. Effective April 1, 2010 through
October 3, 2011, amend 40 CFR 52.21 to
add (i)(l)(vii) to read as follows:
■
erowe on DSK5CLS3C1PROD with RULES
[EPA–HQ–OPP–2009–0714; FRL–8816–3]
*
*
*
*
(i) * * *
(1) * * *
(vii) The source or modification
would be a major stationary source or
major modification only if fugitive
emissions, to the extent quantifiable, are
considered in calculating the potential
to emit of the stationary source or
modification and the source does not
belong to any of the following
categories:
(a) Coal cleaning plants (with thermal
dryers);
(b) Kraft pulp mills;
(c) Portland cement plants;
(d) Primary zinc smelters;
(e) Iron and steel mills;
(f) Primary aluminum ore reduction
plants;
(g) Primary copper smelters;
(h) Municipal incinerators capable of
charging more than 250 tons of refuse
per day;
(i) Hydrofluoric, sulfuric, or nitric
acid plants;
(j) Petroleum refineries;
(k) Lime plants;
(l) Phosphate rock processing plants;
(m) Coke oven batteries;
(n) Sulfur recovery plants;
(o) Carbon black plants (furnace
process);
(p) Primary lead smelters;
(q) Fuel conversion plants;
(r) Sintering plants;
(s) Secondary metal production
plants;
(t) Chemical process plants—The term
chemical processing plant shall not
include ethanol production facilities
that produce ethanol by natural
fermentation included in NAICS codes
325193 or 312140;
(u) Fossil-fuel boilers (or combination
thereof) totaling more than 250 million
British thermal units per hour heat
input;
(v) Petroleum storage and transfer
units with a total storage capacity
exceeding 300,000 barrels;
(w) Taconite ore processing plants;
(x) Glass fiber processing plants;
(y) Charcoal production plants;
(z) Fossil fuel-fired steam electric
plants of more than 250 million British
thermal units per hour heat input;
(aa) Any other stationary source
category which, as of August 7, 1980, is
being regulated under section 111 or
112 of the Act; or
*
*
*
*
*
[FR Doc. 2010–7036 Filed 3–30–10; 8:45 am]
BILLING CODE 6560–50–P
VerDate Nov<24>2008
14:09 Mar 30, 2010
Jkt 220001
Cloquintocet-mexyl; Pesticide
Tolerances
AGENCY: Environmental Protection
Agency (EPA).
ACTION: Final rule.
SUMMARY: EPA is amending 40 CFR
180.560 to add a reference to the active
ingredient flucarbazone-sodium (wheat
only) to the tolerance for the inert
ingredient cloquintocet-mexyl (acetic
acid [(5-chloro-8-quinolinyl) oxy]-, 1methylhexyl ester; CAS Reg. No. 99607–
70–2) and its acid metabolite (5-chloro8-quinolinoxyacetic acid) on wheat
forage, wheat grain, wheat hay, and
wheat straw. Arysta LifeScience North
America, LLC requested this tolerance
amendment under the Federal Food,
Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective
March 31, 2010. Objections and requests
for hearings must be received on or
before June 1, 2010, and must be filed
in accordance with the instructions
provided in 40 CFR part 178 (see also
Unit I.C. of the SUPPLEMENTARY
INFORMATION).
EPA has established a
docket for this action under docket
identification (ID) number EPA–HQ–
OPP–2009–0714. All documents in the
docket are listed in the docket index
available at https://www.regulations.gov.
Although listed in the index, some
information is not publicly available,
e.g., Confidential Business Information
(CBI) or other information whose
disclosure is restricted by statute.
Certain other material, such as
copyrighted material, is not placed on
the Internet and will be publicly
available only in hard copy form.
Publicly available docket materials are
available in the electronic docket at
https://www.regulations.gov, or, if only
available in hard copy, at the OPP
Regulatory Public Docket in Rm. S–
4400, One Potomac Yard (South Bldg.),
2777 S. Crystal Dr., Arlington, VA. The
Docket Facility is open from 8:30 a.m.
to 4 p.m., Monday through Friday,
excluding legal holidays. The Docket
Facility telephone number is (703) 305–
5805.
FOR FURTHER INFORMATION CONTACT:
Karen Samek, Registration division
(7505P), Office of Pesticide Programs,
Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington,
DC 20460–0001; telephone number:
ADDRESSES:
PO 00000
Frm 00027
Fmt 4700
(703) 347–8825; e-mail address:
samek.karen@epa.gov.
SUPPLEMENTARY INFORMATION:
40 CFR Part 180
§ 52.21 Prevention of significant
deterioration of air quality.
*
ENVIRONMENTAL PROTECTION
AGENCY
16017
Sfmt 4700
I. General Information
A. Does this Action Apply to Me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. Potentially
affected entities may include, but are
not limited to those engaged in the
following activities:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
This listing is not intended to be
exhaustive, but rather to provide a guide
for readers regarding entities likely to be
affected by this action. Other types of
entities not listed in this unit could also
be affected. The North American
Industrial Classification System
(NAICS) codes have been provided to
assist you and others in determining
whether this action might apply to
certain entities. If you have any
questions regarding the applicability of
this action to a particular entity, consult
the person listed under FOR FURTHER
INFORMATION CONTACT.
B. How Can I Get Electronic Access to
Other Related Information?
You may access a frequently updated
electronic version of EPA’s tolerance
regulations at 40 CFR part 180 through
the Government Printing Office’s e-CFR
cite at https://www.gpoaccess.gov/ecfr.
C. Can I File an Objection or Hearing
Request?
Under section 408(g) of FFDCA, 21
U.S.C. 346a, any person may file an
objection to any aspect of this regulation
and may also request a hearing on those
objections. You must file your objection
or request a hearing on this regulation
in accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
identify docket ID number EPA–HQ–
OPP–2009–0714 in the subject line on
the first page of your submission. All
requests must be in writing, and must be
mailed or delivered to the Hearing Clerk
as required by 40 CFR part 178 on or
before June 1, 2010.
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing that does not
contain any CBI for inclusion in the
public docket that is described in
E:\FR\FM\31MRR1.SGM
31MRR1
16018
Federal Register / Vol. 75, No. 61 / Wednesday, March 31, 2010 / Rules and Regulations
ADDRESSES. Information not marked
confidential pursuant to 40 CFR part 2
may be disclosed publicly by EPA
without prior notice. Submit this copy,
identified by docket ID number EPA–
HQ–OPP–2009–0714, by one of the
following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the on-line
instructions for submitting comments.
• Mail: Office of Pesticide Programs
(OPP) Regulatory Public Docket (7502P),
Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington,
DC 20460–0001.
• Delivery: OPP Regulatory Public
Docket (7502P), Environmental
Protection Agency, Rm. S–4400, One
Potomac Yard (South Bldg.), 2777 S.
Crystal Dr., Arlington, VA. Deliveries
are only accepted during the Docket
Facility’s normal hours of operation
(8:30 a.m. to 4 p.m., Monday through
Friday, excluding legal holidays).
Special arrangements should be made
for deliveries of boxed information. The
Docket Facility telephone number is
(703) 305–5805.
erowe on DSK5CLS3C1PROD with RULES
II. Petition for Tolerance
EPA has received a petition from
Arysta LifeScience North America, LLC,
15401 Weston Parkway, Cary, NC
27513, requesting an amendment to the
existing tolerances for the inert
ingredient (safener) (acetic acid [(5chloro-8-quinolinyl) oxy]-, 1methylhexyl ester; CAS Reg. No. 99607–
70–2) and its acid metabolite (5-chloro8-quinolinoxyacetic acid). For ease of
reading this document, acetic acid [(5chloro-8-quinolinyl) oxy]-, 1methylhexyl ester will be referred to as
cloquintocet-mexyl. EPA published two
final rules to establish tolerances for the
safener under 40 CFR 180.560 in the
Federal Register of June 22, 2000 (65 FR
38757) (FRL–6592–4) and the Federal
Register of December 16, 2005 (70 FR
74679) (FRL–7753–4). These tolerances
establish tolerances for cloquintocetmexyl when used as an inert ingredient
(safener) in pesticide formulations
containing the active ingredients
pinoxaden (wheat or barley) or
clodinafop-propargyl (wheat only). In
addition, a final rule that established
tolerances for this safener was
published in the Federal Register of
March 5, 2008 (73 FR 11816) (FRL–
8350–8). That final rule amended 40
CFR 180.560 by adding a reference to
the active ingredient pyroxsulam (wheat
only), and increased the existing
tolerances for residues of cloquintocetmexyl in or on wheat, forage and wheat,
hay, and removed the specification of a
1:4 ratio inert ingredient safener to
VerDate Nov<24>2008
14:09 Mar 30, 2010
Jkt 220001
active ingredient from the tolerance
expression.
In the Federal Register of October 7,
2009 (74 FR 51597) (FRL–8792–7), EPA
issued a notice pursuant to section
408(d)(3) of FFDCA, 21 U.S.C.
346a(d)(3), announcing the filing of the
above-referenced pesticide petition (PP
9E7592) by Arysta LifeScience North
America, LLC. The petition requested
that 40 CFR 180.560 be amended by
expanding the tolerance to cover
cloquintocet-mexyl residues when used
in formulation with the active
ingredient flucarbazone-sodium on
wheat. No numerical change to the
tolerances for the specific wheat
commodities was sought. That notice
referenced a summary of the petition
prepared by Arysta LifeScience North
America, LLC, the registrant, which is
available to the public in the docket,
https://www.regulations.gov. There were
no comments received in response to
the notice of filing.
III. Aggregate Risk Assessment and
Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA
allows EPA to establish a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the tolerance is ‘‘safe.’’
Section 408(b)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and in
residential settings, but does not include
occupational exposure. Section
408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure
of infants and children to the pesticide
chemical residue in establishing a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue. . . .’’
Consistent with section 408(b)(2)(D)
of FFDCA, and the factors specified in
section 408(b)(2)(D) of FFDCA, EPA has
reviewed the available scientific data
and other relevant information in
support of this action. EPA has
sufficient data to assess the hazards of
and to make a determination on
aggregate exposure for the chemical.
The Agency’s decision document for
this action is available on EPA’s
Electronic Docket at https://
www.regulations.gov/ under docket ID
number EPA–HQ–OPP–2009–0714. For
the full toxicity data and information on
which this risk assessment is based, the
PO 00000
Frm 00028
Fmt 4700
Sfmt 4700
reader is referred to the final rules
establishing tolerances for cloquintocetmexyl that published in in the Federal
Register of March 5, 2008, December 16,
2005, and June 22, 2000.
A. Toxicological Profile
EPA has evaluated the available
toxicity data and considered its validity,
completeness, and reliability as well as
the relationship of the results of the
studies to human risk. EPA has also
considered available information
concerning the variability of the
sensitivities of major identifiable
subgroups of consumers, including
infants and children. Specific
information on the studies received and
the nature of the adverse effects caused
by cloquintocet-mexyl as well as the noobserved-adverse-effect-level (NOAEL)
and the lowest-observed-adverse-effectlevel (LOAEL) from the toxicity studies
are discussed in the final rules
published on March 5, 2008, December
16, 2005, and June 22, 2000. In these
final rules, the Agency reviewed the
available information on cloquintocetmexyl submitted by the petitioners as
well as additional information available
to EPA. The toxicity database is
sufficient for cloquintocet-mexyl and
has not changed since the time of those
publications. Therefore, only a brief
summary is provided here.
Cloquintocet-mexyl has a low order of
acute oral, dermal, and inhalation
toxicity. It is slightly irritating to the
eyes and non-irritating to the skin.
Cloquintocet-mexyl is a skin sensitizer.
The chemical is not genotoxic and is not
a reproductive and developmental
toxicant. There is no evidence of
neurotoxicity in the available studies.
Cloquintocet-mexyl is classified as ‘‘not
likely to be a human carcinogen.’’ The
main metabolite for cloquintocet-mexyl
is 5-chloro-8-quin-linoxyacetic acid, and
testing on the metabolite is part of the
toxicology database for cloquintocetmexyl. For additional information on
the human health toxicity data for
cloquintocet-mexyl and its metabolite,
see EPA’s Electronic Docket at https://
www regulations.gov and the Federal
Register of March 5, 2008, December 16,
2005, and June 22, 2000.
B. Exposure Assessment
In examining aggregate exposure, the
FFDCA section 408 directs EPA to
consider available information
concerning exposures from the pesticide
residue in food and all other nonoccupational exposures, including
drinking water from ground water or
surface water and exposure through
pesticide use in gardens, lawns, or
buildings (residential and other indoor
E:\FR\FM\31MRR1.SGM
31MRR1
Federal Register / Vol. 75, No. 61 / Wednesday, March 31, 2010 / Rules and Regulations
uses). In the 2008 rulemaking, EPA
assessed human exposure to
cloquintocet-mexyl from use on wheat
and barley. EPA assumed that 100% of
the wheat and barley crops were treated
with cloquintocet-mexyl and that
residues on all wheat and barley
commodities were at the tolerance level.
The Agency has determined that this
assessment is sufficient for the current
amendment to the cloquintocet-mexyl
tolerance expression because no new
crops are being added and the label
requirements limit the total number of
applications from all of the various
cloquintocet-mexyl safener products to
one application from this group of
pesticides on a crop per growing season.
For additional information on the
exposure assessment for cloquintocetmexyl, see the docket and the Federal
Register of March 5, 2008.
erowe on DSK5CLS3C1PROD with RULES
C. Cumulative Effects From Substances
With a Common Mechanism of Toxicity
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance, the Agency consider
‘‘available information’’ concerning the
cumulative effects of a particular
pesticide’s residues and ‘‘other
substances that have a common
mechanism of toxicity.’’
EPA has not found cloquintocetmexyl to share a common mechanism of
toxicity with any other substances, and
cloquintocet-mexyl does not appear to
produce a toxic metabolite produced by
other substances. For the purposes of
this tolerance action, therefore, EPA has
assumed that cloquintocet-mexyl does
not have a common mechanism of
toxicity with other substances. For
information regarding EPA’s efforts to
determine which chemicals have a
common mechanism of toxicity and to
evaluate the cumulative effects of such
chemicals, see EPA’s website at https://
www.epa.gov/pesticides/cumulative.
D. Safety Factor for Infants and
Children
1. In general. Section 408(b)(2)(C) of
FFDCA provides that EPA shall apply
an additional tenfold (10X) margin of
safety for infants and children in the
case of threshold effects to account for
prenatal and postnatal toxicity and the
completeness of the database on toxicity
and exposure unless EPA determines
based on reliable data that a different
margin of safety will be safe for infants
and children. This additional margin of
safety is commonly referred to as the
FQPA SF. In applying this provision,
EPA either retains the default value of
10X, or uses a different additional safety
factor when reliable data available to
VerDate Nov<24>2008
14:09 Mar 30, 2010
Jkt 220001
EPA support the choice of a different
factor.
2. Prenatal and postnatal sensitivity.
There was no evidence of increased
susceptibility of in utero or post-natal
exposure to rats or rabbits in the
prenatal developmental studies or in
rats in the 2-generation reproduction
study. NOAELs for maternal/parental
toxicity were either less than or equal to
the NOAELs for fetal or reproductive
toxicity.
3. Conclusion. EPA has determined
that reliable data show that the safety of
infants and children would be
adequately protected if the FQPA SF
were reduced to 1X. That decision is
based on the following findings:
i. The toxicity database for
cloquintocet-mexyl is complete, except
for immunotoxicity and neurotoxicity
studies. EPA began requiring these
studies on December 26, 2009. In the
absence of specific immunotoxicity
studies, EPA has evaluated the available
toxicity data for cloquintocet-mexyl and
determined that an additional database
uncertainty factor is not needed to
account for potential immunotoxicity.
EPA’s determination is based on the
following considerations.
There was some indication of possible
immunotoxicity in the form of
lymphoid hyperplasia of the thymus in
male rats (without any histopathology
changes in the study) at the LOAEL of
73.5 milligrams/kilogram/day (mg/kg/
day) in the combined chronic/
oncogenicity study in rats (with a
NOAEL of 36.4 mg/kg/day). This effect
was observed only in males. No blood
parameters were affected. In addition,
cloquintocet-mexyl does not belong to a
class of chemicals that would be
expected to be immunotoxic. A clear
NOAEL was established for these effects
(36.4 mg/kg/day), and the regulatory
endpoint of 4.3 mg/kg/day (the NOAEL
from the combined chronic/
oncogenicity study) is nearly 10X below
the NOAEL for the possible
immunotoxic effect. Therefore, based on
the considerations in this unit, EPA
does not believe that conducting
immunotoxicity testing will result in a
NOAEL significantly less than the
NOAEL of 4.3 mg/kg/day already
established for cloquintocet-mexyl, and
an additional factor (UFDB) for database
uncertainties is not needed to account
for potential immunotoxicity. A
confirmatory immunotoxicity study will
be required as a condition of the
registration.
No acute and subchronic
neurotoxicity studies are available,
however, there is no evidence of
neurotoxicity in the toxicology database
on cloquintocet-mexyl. Therefore, based
PO 00000
Frm 00029
Fmt 4700
Sfmt 4700
16019
on the considerations in this unit, the
Agency does not believe that conducting
acute and subchronic neurotixicty
studies will result in a NOAEL less than
the NOAEL of 4.3 mg/kg/day. Therefore,
there is no need for additional
uncertainty factors (UF). Confirmatory
acute and subchronic neurotoxicity
studies will be required as a condition
of registration.
ii. There is no indication of
quantitative or qualitative increased
susceptibility of rats or rabbits to in
utero and/or postnatal exposure to
cloquintocet-mexyl in the available
toxicity database.
iii. There is no indication that
cloquinocet-mexyl is a neurotoxic
chemical and thus there is no need for
a developmental neurotoxicity study or
additional UFs to account for
neurotoxicity.
iv. The dietary (food and drinking
water) exposure assessments will not
underestimate the potential exposures
for infants and children from the use of
cloquintocet-mexyl (currently there are
no proposed residential uses and
therefore non-occupational exposure is
not expected).
For additional information on the
Safety Factor determination for infants
and children for cloquintocet-mexyl, see
the docket and the Federal Register of
March 5, 2008.
E. Aggregate Risks and Determination of
Safety
EPA determines whether acute and
chronic pesticide exposures are safe by
comparing aggregate exposure estimates
to the acute population adjusted dose
(aPAD) and chronic population adjusted
dose (cPAD). The aPAD and cPAD
represent the highest safe exposures,
taking into account all appropriate safty
factors (SFs). EPA calculates the aPAD
and cPAD by dividing the point of
departure (POD) by all applicable UFs.
For linear cancer risks, EPA calculates
the probability of additional cancer
cases given the estimated aggregate
exposure. Short-term, intermediateterm, and chronic-term risks are
evaluated by comparing the estimated
aggregate food, water, and residential
exposure to the POD to ensure that the
margin of exposure (MOE) called for by
the product of all applicable UFs is not
exceeded.
In the 2005 and 2008 rulemakings for
cloquintocet-mexyl, EPA concluded that
aggregate risks from exposure to
cloquintocet-mexyl did not exceed 1%
of the aPAD or cPAD for the most
exposed population groups. (73 FR
11819); (70 FR 74685). These findings
are applicable to this tolerance
amendment.
E:\FR\FM\31MRR1.SGM
31MRR1
16020
Federal Register / Vol. 75, No. 61 / Wednesday, March 31, 2010 / Rules and Regulations
Based on these risk assessments, EPA
concludes that there is a reasonable
certainty that no harm will result to the
general population, or to infants and
children from aggregate exposure to
cloquintocet-mexyl and its acid
metabolite (5-chloro-8quinolinoxyacetic acid).
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodology
is available to enforce the tolerance
expression. The method may be
requested from: Chief, Analytical
Chemistry Branch, Enviromental
Science Center, 701 Mapes Rd., Ft.
Meade, MD 20755–5350; e-mail address:
residuemethods@epa.gov. For the
complete description of Analytical
Methods for cloquintocet-mexyl, see the
docket and the Federal Register of
December 16, 2005.
B. International Residue Limits
There are no Codex tolerances for
cloquintocet-mexyl.
erowe on DSK5CLS3C1PROD with RULES
V. Conclusions
Therefore, 40 CFR 180.560 is
amended by establishing a tolerance for
the combined residues of cloquintocetmexyl (acetic acid [(5-chloro-8quinolinyl) oxy]-, 1-methylhexyl ester;
CAS Reg. No. 99607–70–2) and its acid
metabolite (5-chloro-8-quinlinoxyacetic
acid) when used as an inert ingredient
(safener) in pesticide formulations
containing the active ingredients
flucarbazone-sodium (wheat only),
pinoxaden (wheat or barley),
clodinafop-propargyl (wheat only), or
pyroxsulum (wheat only) in or on
barley, grain at 0.1 ppm; barley, hay at
0.1 ppm; barley, straw at 0.1 ppm;
wheat, forage at 0.2 ppm; wheat, grain
at 0.1 ppm; wheat, hay at 0.5 ppm; and
wheat, straw at 0.1 ppm.
VI. Statutory and Executive Order
Reviews
This final rule establishes tolerances
under section 408(d) of FFDCA in
response to a petition submitted to the
Agency. The Office of Management and
Budget (OMB) has exempted these types
of actions from review under Executive
Order 12866, entitled Regulatory
Planning and Review (58 FR 51735,
October 4, 1993). Because this final rule
has been exempted from review under
Executive Order 12866, this final rule is
not subject to Executive Order 13211,
entitled Actions Concerning Regulations
That Significantly Affect Energy Supply,
Distribution, or Use (66 FR 28355, May
22, 2001) or Executive Order 13045,
entitled Protection of Children from
Environmental Health Risks and Safety
VerDate Nov<24>2008
14:09 Mar 30, 2010
Jkt 220001
Risks (62 FR 19885, April 23, 1997).
This final rule does not contain any
information collections subject to OMB
approval under the Paperwork
Reduction Act (PRA), 44 U.S.C. 3501 et
seq., nor does it require any special
considerations under Executive Order
12898, entitled Federal Actions to
Address Environmental Justice in
Minority Populations and Low-Income
Populations (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under section 408(d) of FFDCA, such as
the tolerance in this final rule, do not
require the issuance of a proposed rule,
the requirements of the Regulatory
Flexibility Act (RFA) (5 U.S.C. 601 et
seq.) do not apply.
This final rule directly regulates
growers, food processors, food handlers,
and food retailers, not States or tribes,
nor does this action alter the
relationships or distribution of power
and responsibilities established by
Congress in the preemption provisions
of section 408(n)(4) of FFDCA. As such,
the Agency has determined that this
action will not have a substantial direct
effect on States or tribal governments,
on the relationship between the national
government and the States or tribal
governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
tribes. Thus, the Agency has determined
that Executive Order 13132, entitled
Federalism (64 FR 43255, August 10,
1999) and Executive Order 13175,
entitled Consultation and Coordination
with Indian Tribal Governments (65 FR
67249, November 9, 2000) do not apply
to this final rule. In addition, this final
rule does not impose any enforceable
duty or contain any unfunded mandate
as described under Title II of the
Unfunded Mandates Reform Act of 1995
(UMRA) (Public Law 104–4).
This action does not involve any
technical standards that would require
Agency consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act of 1995
(NTTAA), Public Law 104–113, section
12(d) (15 U.S.C. 272 note).
VII. Congressional Review Act
The Congressional Review Act, 5
U.S.C. 801 et seq., generally provides
that before a rule may take effect, the
agency promulgating the rule must
submit a rule report to each House of
the Congress and to the Comptroller
General of the United States. EPA will
submit a report containing this rule and
other required information to the U.S.
PO 00000
Frm 00030
Fmt 4700
Sfmt 9990
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of this final rule in the
Federal Register. This final rule is not
a ‘‘major rule’’ as defined by 5 U.S.C.
804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: March 22, 2010.
Lois Rossi,
Director, Registration Division, Office of
Pesticide Programs.
Therefore, 40 CFR chapter I is
amended as follows:
■
PART 180—[AMENDED]
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
2. Section 180.560, revise paragraph
(a) to read as follows:
■
§ 180.560 Cloquintocet-mexyl; tolerances
for residues.
(a) General. Tolerances are
established for the combined residues of
cloquintocet-mexyl (acetic acid [(5chloro-8-quinolinyl) oxy]-, 1methylhexyl ester; CAS Reg. No. 99607–
70–2) and its acid metabolite (5-chloro8-quinlinoxyacetic acid) when used as
an inert ingredient (safener) in pesticide
formulations containing the active
ingredients, flucarbazone-sodium
(wheat only), pinoxaden (wheat or
barley), clodinafop-propargyl (wheat
only), or pyroxsulum (wheat only) in or
on the following food commodities:
Parts per
million
Commodity
Barley, grain .........................
Barley, hay ............................
Barley, straw .........................
Wheat, forage .......................
Wheat, grain .........................
Wheat, hay ...........................
Wheat, straw .........................
*
*
*
*
*
[FR Doc. 2010–6890 Filed 3–30–10; 8:45 am]
BILLING CODE 6560–50–S
E:\FR\FM\31MRR1.SGM
31MRR1
0.1
0.1
0.1
0.2
0.1
0.5
0.1
Agencies
[Federal Register Volume 75, Number 61 (Wednesday, March 31, 2010)]
[Rules and Regulations]
[Pages 16017-16020]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-6890]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2009-0714; FRL-8816-3]
Cloquintocet-mexyl; Pesticide Tolerances
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: EPA is amending 40 CFR 180.560 to add a reference to the
active ingredient flucarbazone-sodium (wheat only) to the tolerance for
the inert ingredient cloquintocet-mexyl (acetic acid [(5-chloro-8-
quinolinyl) oxy]-, 1-methylhexyl ester; CAS Reg. No. 99607-70-2) and
its acid metabolite (5-chloro-8-quinolinoxyacetic acid) on wheat
forage, wheat grain, wheat hay, and wheat straw. Arysta LifeScience
North America, LLC requested this tolerance amendment under the Federal
Food, Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective March 31, 2010. Objections and
requests for hearings must be received on or before June 1, 2010, and
must be filed in accordance with the instructions provided in 40 CFR
part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: EPA has established a docket for this action under docket
identification (ID) number EPA-HQ-OPP-2009-0714. All documents in the
docket are listed in the docket index available at https://www.regulations.gov. Although listed in the index, some information is
not publicly available, e.g., Confidential Business Information (CBI)
or other information whose disclosure is restricted by statute. Certain
other material, such as copyrighted material, is not placed on the
Internet and will be publicly available only in hard copy form.
Publicly available docket materials are available in the electronic
docket at https://www.regulations.gov, or, if only available in hard
copy, at the OPP Regulatory Public Docket in Rm. S-4400, One Potomac
Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. The Docket
Facility is open from 8:30 a.m. to 4 p.m., Monday through Friday,
excluding legal holidays. The Docket Facility telephone number is (703)
305-5805.
FOR FURTHER INFORMATION CONTACT: Karen Samek, Registration division
(7505P), Office of Pesticide Programs, Environmental Protection Agency,
1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone
number: (703) 347-8825; e-mail address: samek.karen@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this Action Apply to Me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
Potentially affected entities may include, but are not limited to those
engaged in the following activities:
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
This listing is not intended to be exhaustive, but rather to
provide a guide for readers regarding entities likely to be affected by
this action. Other types of entities not listed in this unit could also
be affected. The North American Industrial Classification System
(NAICS) codes have been provided to assist you and others in
determining whether this action might apply to certain entities. If you
have any questions regarding the applicability of this action to a
particular entity, consult the person listed under FOR FURTHER
INFORMATION CONTACT.
B. How Can I Get Electronic Access to Other Related Information?
You may access a frequently updated electronic version of EPA's
tolerance regulations at 40 CFR part 180 through the Government
Printing Office's e-CFR cite at https://www.gpoaccess.gov/ecfr.
C. Can I File an Objection or Hearing Request?
Under section 408(g) of FFDCA, 21 U.S.C. 346a, any person may file
an objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2009-0714 in the subject line on the first
page of your submission. All requests must be in writing, and must be
mailed or delivered to the Hearing Clerk as required by 40 CFR part 178
on or before June 1, 2010.
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing that does not contain any CBI for inclusion in the public
docket that is described in
[[Page 16018]]
ADDRESSES. Information not marked confidential pursuant to 40 CFR part
2 may be disclosed publicly by EPA without prior notice. Submit this
copy, identified by docket ID number EPA-HQ-OPP-2009-0714, by one of
the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the on-line instructions for submitting comments.
Mail: Office of Pesticide Programs (OPP) Regulatory Public
Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460-0001.
Delivery: OPP Regulatory Public Docket (7502P),
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only
accepted during the Docket Facility's normal hours of operation (8:30
a.m. to 4 p.m., Monday through Friday, excluding legal holidays).
Special arrangements should be made for deliveries of boxed
information. The Docket Facility telephone number is (703) 305-5805.
II. Petition for Tolerance
EPA has received a petition from Arysta LifeScience North America,
LLC, 15401 Weston Parkway, Cary, NC 27513, requesting an amendment to
the existing tolerances for the inert ingredient (safener) (acetic acid
[(5-chloro-8-quinolinyl) oxy]-, 1-methylhexyl ester; CAS Reg. No.
99607-70-2) and its acid metabolite (5-chloro-8-quinolinoxyacetic
acid). For ease of reading this document, acetic acid [(5-chloro-8-
quinolinyl) oxy]-, 1-methylhexyl ester will be referred to as
cloquintocet-mexyl. EPA published two final rules to establish
tolerances for the safener under 40 CFR 180.560 in the Federal Register
of June 22, 2000 (65 FR 38757) (FRL-6592-4) and the Federal Register of
December 16, 2005 (70 FR 74679) (FRL-7753-4). These tolerances
establish tolerances for cloquintocet-mexyl when used as an inert
ingredient (safener) in pesticide formulations containing the active
ingredients pinoxaden (wheat or barley) or clodinafop-propargyl (wheat
only). In addition, a final rule that established tolerances for this
safener was published in the Federal Register of March 5, 2008 (73 FR
11816) (FRL-8350-8). That final rule amended 40 CFR 180.560 by adding a
reference to the active ingredient pyroxsulam (wheat only), and
increased the existing tolerances for residues of cloquintocet-mexyl in
or on wheat, forage and wheat, hay, and removed the specification of a
1:4 ratio inert ingredient safener to active ingredient from the
tolerance expression.
In the Federal Register of October 7, 2009 (74 FR 51597) (FRL-8792-
7), EPA issued a notice pursuant to section 408(d)(3) of FFDCA, 21
U.S.C. 346a(d)(3), announcing the filing of the above-referenced
pesticide petition (PP 9E7592) by Arysta LifeScience North America,
LLC. The petition requested that 40 CFR 180.560 be amended by expanding
the tolerance to cover cloquintocet-mexyl residues when used in
formulation with the active ingredient flucarbazone-sodium on wheat. No
numerical change to the tolerances for the specific wheat commodities
was sought. That notice referenced a summary of the petition prepared
by Arysta LifeScience North America, LLC, the registrant, which is
available to the public in the docket, https://www.regulations.gov.
There were no comments received in response to the notice of filing.
III. Aggregate Risk Assessment and Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a
tolerance (the legal limit for a pesticide chemical residue in or on a
food) only if EPA determines that the tolerance is ``safe.'' Section
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a
reasonable certainty that no harm will result from aggregate exposure
to the pesticide chemical residue, including all anticipated dietary
exposures and all other exposures for which there is reliable
information.'' This includes exposure through drinking water and in
residential settings, but does not include occupational exposure.
Section 408(b)(2)(C) of FFDCA requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical residue. . .
.''
Consistent with section 408(b)(2)(D) of FFDCA, and the factors
specified in section 408(b)(2)(D) of FFDCA, EPA has reviewed the
available scientific data and other relevant information in support of
this action. EPA has sufficient data to assess the hazards of and to
make a determination on aggregate exposure for the chemical. The
Agency's decision document for this action is available on EPA's
Electronic Docket at https://www.regulations.gov/ under docket ID number
EPA-HQ-OPP-2009-0714. For the full toxicity data and information on
which this risk assessment is based, the reader is referred to the
final rules establishing tolerances for cloquintocet-mexyl that
published in in the Federal Register of March 5, 2008, December 16,
2005, and June 22, 2000.
A. Toxicological Profile
EPA has evaluated the available toxicity data and considered its
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children. Specific information on the studies received and the nature
of the adverse effects caused by cloquintocet-mexyl as well as the no-
observed-adverse-effect-level (NOAEL) and the lowest-observed-adverse-
effect-level (LOAEL) from the toxicity studies are discussed in the
final rules published on March 5, 2008, December 16, 2005, and June 22,
2000. In these final rules, the Agency reviewed the available
information on cloquintocet-mexyl submitted by the petitioners as well
as additional information available to EPA. The toxicity database is
sufficient for cloquintocet-mexyl and has not changed since the time of
those publications. Therefore, only a brief summary is provided here.
Cloquintocet-mexyl has a low order of acute oral, dermal, and
inhalation toxicity. It is slightly irritating to the eyes and non-
irritating to the skin. Cloquintocet-mexyl is a skin sensitizer. The
chemical is not genotoxic and is not a reproductive and developmental
toxicant. There is no evidence of neurotoxicity in the available
studies. Cloquintocet-mexyl is classified as ``not likely to be a human
carcinogen.'' The main metabolite for cloquintocet-mexyl is 5-chloro-8-
quin-linoxyacetic acid, and testing on the metabolite is part of the
toxicology database for cloquintocet-mexyl. For additional information
on the human health toxicity data for cloquintocet-mexyl and its
metabolite, see EPA's Electronic Docket at https://www regulations.gov
and the Federal Register of March 5, 2008, December 16, 2005, and June
22, 2000.
B. Exposure Assessment
In examining aggregate exposure, the FFDCA section 408 directs EPA
to consider available information concerning exposures from the
pesticide residue in food and all other non-occupational exposures,
including drinking water from ground water or surface water and
exposure through pesticide use in gardens, lawns, or buildings
(residential and other indoor
[[Page 16019]]
uses). In the 2008 rulemaking, EPA assessed human exposure to
cloquintocet-mexyl from use on wheat and barley. EPA assumed that 100%
of the wheat and barley crops were treated with cloquintocet-mexyl and
that residues on all wheat and barley commodities were at the tolerance
level. The Agency has determined that this assessment is sufficient for
the current amendment to the cloquintocet-mexyl tolerance expression
because no new crops are being added and the label requirements limit
the total number of applications from all of the various cloquintocet-
mexyl safener products to one application from this group of pesticides
on a crop per growing season. For additional information on the
exposure assessment for cloquintocet-mexyl, see the docket and the
Federal Register of March 5, 2008.
C. Cumulative Effects From Substances With a Common Mechanism of
Toxicity
Section 408(b)(2)(D)(v) of FFDCA requires that, when considering
whether to establish, modify, or revoke a tolerance, the Agency
consider ``available information'' concerning the cumulative effects of
a particular pesticide's residues and ``other substances that have a
common mechanism of toxicity.''
EPA has not found cloquintocet-mexyl to share a common mechanism of
toxicity with any other substances, and cloquintocet-mexyl does not
appear to produce a toxic metabolite produced by other substances. For
the purposes of this tolerance action, therefore, EPA has assumed that
cloquintocet-mexyl does not have a common mechanism of toxicity with
other substances. For information regarding EPA's efforts to determine
which chemicals have a common mechanism of toxicity and to evaluate the
cumulative effects of such chemicals, see EPA's website at https://www.epa.gov/pesticides/cumulative.
D. Safety Factor for Infants and Children
1. In general. Section 408(b)(2)(C) of FFDCA provides that EPA
shall apply an additional tenfold (10X) margin of safety for infants
and children in the case of threshold effects to account for prenatal
and postnatal toxicity and the completeness of the database on toxicity
and exposure unless EPA determines based on reliable data that a
different margin of safety will be safe for infants and children. This
additional margin of safety is commonly referred to as the FQPA SF. In
applying this provision, EPA either retains the default value of 10X,
or uses a different additional safety factor when reliable data
available to EPA support the choice of a different factor.
2. Prenatal and postnatal sensitivity. There was no evidence of
increased susceptibility of in utero or post-natal exposure to rats or
rabbits in the prenatal developmental studies or in rats in the 2-
generation reproduction study. NOAELs for maternal/parental toxicity
were either less than or equal to the NOAELs for fetal or reproductive
toxicity.
3. Conclusion. EPA has determined that reliable data show that the
safety of infants and children would be adequately protected if the
FQPA SF were reduced to 1X. That decision is based on the following
findings:
i. The toxicity database for cloquintocet-mexyl is complete, except
for immunotoxicity and neurotoxicity studies. EPA began requiring these
studies on December 26, 2009. In the absence of specific immunotoxicity
studies, EPA has evaluated the available toxicity data for
cloquintocet-mexyl and determined that an additional database
uncertainty factor is not needed to account for potential
immunotoxicity. EPA's determination is based on the following
considerations.
There was some indication of possible immunotoxicity in the form of
lymphoid hyperplasia of the thymus in male rats (without any
histopathology changes in the study) at the LOAEL of 73.5 milligrams/
kilogram/day (mg/kg/day) in the combined chronic/oncogenicity study in
rats (with a NOAEL of 36.4 mg/kg/day). This effect was observed only in
males. No blood parameters were affected. In addition, cloquintocet-
mexyl does not belong to a class of chemicals that would be expected to
be immunotoxic. A clear NOAEL was established for these effects (36.4
mg/kg/day), and the regulatory endpoint of 4.3 mg/kg/day (the NOAEL
from the combined chronic/oncogenicity study) is nearly 10X below the
NOAEL for the possible immunotoxic effect. Therefore, based on the
considerations in this unit, EPA does not believe that conducting
immunotoxicity testing will result in a NOAEL significantly less than
the NOAEL of 4.3 mg/kg/day already established for cloquintocet-mexyl,
and an additional factor (UFDB) for database uncertainties is not
needed to account for potential immunotoxicity. A confirmatory
immunotoxicity study will be required as a condition of the
registration.
No acute and subchronic neurotoxicity studies are available,
however, there is no evidence of neurotoxicity in the toxicology
database on cloquintocet-mexyl. Therefore, based on the considerations
in this unit, the Agency does not believe that conducting acute and
subchronic neurotixicty studies will result in a NOAEL less than the
NOAEL of 4.3 mg/kg/day. Therefore, there is no need for additional
uncertainty factors (UF). Confirmatory acute and subchronic
neurotoxicity studies will be required as a condition of registration.
ii. There is no indication of quantitative or qualitative
increased susceptibility of rats or rabbits to in utero and/or
postnatal exposure to cloquintocet-mexyl in the available toxicity
database.
iii. There is no indication that cloquinocet-mexyl is a neurotoxic
chemical and thus there is no need for a developmental neurotoxicity
study or additional UFs to account for neurotoxicity.
iv. The dietary (food and drinking water) exposure assessments
will not underestimate the potential exposures for infants and children
from the use of cloquintocet-mexyl (currently there are no proposed
residential uses and therefore non-occupational exposure is not
expected).
For additional information on the Safety Factor determination for
infants and children for cloquintocet-mexyl, see the docket and the
Federal Register of March 5, 2008.
E. Aggregate Risks and Determination of Safety
EPA determines whether acute and chronic pesticide exposures are
safe by comparing aggregate exposure estimates to the acute population
adjusted dose (aPAD) and chronic population adjusted dose (cPAD). The
aPAD and cPAD represent the highest safe exposures, taking into account
all appropriate safty factors (SFs). EPA calculates the aPAD and cPAD
by dividing the point of departure (POD) by all applicable UFs. For
linear cancer risks, EPA calculates the probability of additional
cancer cases given the estimated aggregate exposure. Short-term,
intermediate-term, and chronic-term risks are evaluated by comparing
the estimated aggregate food, water, and residential exposure to the
POD to ensure that the margin of exposure (MOE) called for by the
product of all applicable UFs is not exceeded.
In the 2005 and 2008 rulemakings for cloquintocet-mexyl, EPA
concluded that aggregate risks from exposure to cloquintocet-mexyl did
not exceed 1% of the aPAD or cPAD for the most exposed population
groups. (73 FR 11819); (70 FR 74685). These findings are applicable to
this tolerance amendment.
[[Page 16020]]
Based on these risk assessments, EPA concludes that there is a
reasonable certainty that no harm will result to the general
population, or to infants and children from aggregate exposure to
cloquintocet-mexyl and its acid metabolite (5-chloro-8-
quinolinoxyacetic acid).
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodology is available to enforce the
tolerance expression. The method may be requested from: Chief,
Analytical Chemistry Branch, Enviromental Science Center, 701 Mapes
Rd., Ft. Meade, MD 20755-5350; e-mail address: residuemethods@epa.gov.
For the complete description of Analytical Methods for cloquintocet-
mexyl, see the docket and the Federal Register of December 16, 2005.
B. International Residue Limits
There are no Codex tolerances for cloquintocet-mexyl.
V. Conclusions
Therefore, 40 CFR 180.560 is amended by establishing a tolerance
for the combined residues of cloquintocet-mexyl (acetic acid [(5-
chloro-8-quinolinyl) oxy]-, 1-methylhexyl ester; CAS Reg. No. 99607-70-
2) and its acid metabolite (5-chloro-8-quinlinoxyacetic acid) when used
as an inert ingredient (safener) in pesticide formulations containing
the active ingredients flucarbazone-sodium (wheat only), pinoxaden
(wheat or barley), clodinafop-propargyl (wheat only), or pyroxsulum
(wheat only) in or on barley, grain at 0.1 ppm; barley, hay at 0.1 ppm;
barley, straw at 0.1 ppm; wheat, forage at 0.2 ppm; wheat, grain at 0.1
ppm; wheat, hay at 0.5 ppm; and wheat, straw at 0.1 ppm.
VI. Statutory and Executive Order Reviews
This final rule establishes tolerances under section 408(d) of
FFDCA in response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled Regulatory Planning and
Review (58 FR 51735, October 4, 1993). Because this final rule has been
exempted from review under Executive Order 12866, this final rule is
not subject to Executive Order 13211, entitled Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled
Protection of Children from Environmental Health Risks and Safety Risks
(62 FR 19885, April 23, 1997). This final rule does not contain any
information collections subject to OMB approval under the Paperwork
Reduction Act (PRA), 44 U.S.C. 3501 et seq., nor does it require any
special considerations under Executive Order 12898, entitled Federal
Actions to Address Environmental Justice in Minority Populations and
Low-Income Populations (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under section 408(d) of FFDCA, such as the tolerance in
this final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.) do not apply.
This final rule directly regulates growers, food processors, food
handlers, and food retailers, not States or tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of section 408(n)(4) of FFDCA. As such, the Agency has determined that
this action will not have a substantial direct effect on States or
tribal governments, on the relationship between the national government
and the States or tribal governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian tribes. Thus, the Agency has
determined that Executive Order 13132, entitled Federalism (64 FR
43255, August 10, 1999) and Executive Order 13175, entitled
Consultation and Coordination with Indian Tribal Governments (65 FR
67249, November 9, 2000) do not apply to this final rule. In addition,
this final rule does not impose any enforceable duty or contain any
unfunded mandate as described under Title II of the Unfunded Mandates
Reform Act of 1995 (UMRA) (Public Law 104-4).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act of 1995 (NTTAA), Public Law 104-113, section 12(d) (15 U.S.C. 272
note).
VII. Congressional Review Act
The Congressional Review Act, 5 U.S.C. 801 et seq., generally
provides that before a rule may take effect, the agency promulgating
the rule must submit a rule report to each House of the Congress and to
the Comptroller General of the United States. EPA will submit a report
containing this rule and other required information to the U.S. Senate,
the U.S. House of Representatives, and the Comptroller General of the
United States prior to publication of this final rule in the Federal
Register. This final rule is not a ``major rule'' as defined by 5
U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: March 22, 2010.
Lois Rossi,
Director, Registration Division, Office of Pesticide Programs.
0
Therefore, 40 CFR chapter I is amended as follows:
PART 180--[AMENDED]
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. Section 180.560, revise paragraph (a) to read as follows:
Sec. 180.560 Cloquintocet-mexyl; tolerances for residues.
(a) General. Tolerances are established for the combined residues
of cloquintocet-mexyl (acetic acid [(5-chloro-8-quinolinyl) oxy]-, 1-
methylhexyl ester; CAS Reg. No. 99607-70-2) and its acid metabolite (5-
chloro-8-quinlinoxyacetic acid) when used as an inert ingredient
(safener) in pesticide formulations containing the active ingredients,
flucarbazone-sodium (wheat only), pinoxaden (wheat or barley),
clodinafop-propargyl (wheat only), or pyroxsulum (wheat only) in or on
the following food commodities:
------------------------------------------------------------------------
Parts per
Commodity million
------------------------------------------------------------------------
Barley, grain........................................... 0.1
Barley, hay............................................. 0.1
Barley, straw........................................... 0.1
Wheat, forage........................................... 0.2
Wheat, grain............................................ 0.1
Wheat, hay.............................................. 0.5
Wheat, straw............................................ 0.1
------------------------------------------------------------------------
* * * * *
[FR Doc. 2010-6890 Filed 3-30-10; 8:45 am]
BILLING CODE 6560-50-S